Oral Histories

Sanberg, Paul

Biographical Sketch:

Dr. Sanberg is Chairman and Founder of Saneron CCEL Therapeutics, Inc. in Tampa, Florida. He is also an inventor on approximately 30 health-related patents issued by the U.S. Patent and Trademark Office (USPTO), and numerous foreign patents. His co-discovery of a novel antidepressant drug is in late development by AstraZeneca.

Dr. Sanberg’s early work was pioneering in understanding why brain cells die in neurological disorders and in drug abuse research. He trained at York University, the University of British Columbia, the Australian National University and Johns Hopkins University School of Medicine, among others. Before coming to USF, Dr. Sanberg held academic positions at Ohio University, the University of Cincinnati, and Brown University.
Other industry experience includes Scientific Director for CytoTherapeutics, Inc. in Providence, RI (now Stem Cells, Inc. in Palo Alto, CA), and Chief Scientific Officer and member of the Board of Directors for Layton BioScience, Inc. in Atherton, CA. All of these companies are involved in cell therapy for degenerative disorders. Dr. Sanberg is a member of the Board of Scientific Counselors for the National Institute of Drug Abuse at the National Institutes of Health, and serves on numerous scientific advisory boards for health-related foundations and companies. He is the co-editor-in-chief of Cell Transplantation, editor-in-chief of TECHNOLOGY AND INNOVATION, Proceedings of the National Academy of Inventors, and serves on editorial boards for more than 25 scientific journals.

Dr. Sanberg is the Executive Director of the American Society for Neural Transplantation and Repair, and a past president of the Cell Transplant Society and International Behavioral Neuroscience Society, among others.

His recent research has focused on discovering innovative ways to repair the damaged brain, and has helped lead the team that demonstrated that bone marrow and umbilical cord blood derived stem cells can be transformed to neural cells that may be useful in stroke, spinal cord injury and ALS. Dr. Sanberg’s work has been instrumental in translating new pharmaceutical and cellular therapeutics to clinical trials for Tourette syndrome, depression, stroke, Huntington’s disease and Parkinson’s disease. Dr. Sanberg is the founder of the National Academy of Inventors (at the University of South Florida) and currently serves as its president.

Sanberg, Paul
Topical Index:

Interview History:

Dates: Dec-97
Interviewer: M.



© 2009 UC Regents. All Rights Reserved. Website by Pendari.com